The symposium was supported by KalVista Pharmaceuticals.
Join us for an in-depth look at hereditary angioedema (HAE) in this insightful symposium video from the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024. HAE is a rare genetic disorder characterised by sudden, severe swelling episodes that can be life-threatening. Chaired by Douglas Jones, Rocky Mountain Allergy, Asthma, and Immunology, Layton, Utah, USA, with experts Thomas Buttgereit, Charité – Universitätsmedizin Berlin, Germany; Emily Carne, University Hospital of Wales, Cardiff, UK; and Danny Cohn, Amsterdam University Medical Center, Amsterdam, the Netherlands.
This video explores the challenges HAE patients face and highlights the importance of timely on-demand treatment. Discover how better communication between healthcare providers and patients can improve treatment adherence and learn about new oral treatments in clinical trials that could simplify attack management and enhance quality of life.
Speakers
 |
 |
 |
 |
| Douglas Jones Rocky Mountain Allergy, Asthma, and Immunology, Layton, Utah, USA |
Thomas Buttgereit Charité–Universitätsmedizin Berlin, Germany |
Emily Carne University Hospital of Wales, Cardiff, UK |
Danny Cohn Amsterdam University Medical Center, Amsterdam, the Netherlands |
